Biosite Triage BNP Reduces Diagnosis Uncertainty To 11%, NEJM Study Finds

Biosite plans to file a 510(k) application in mid-2003 seeking a therapeutic monitoring indication for its Triage B-type natriuretic peptide (BNP) test to aid in diagnosis of congestive heart failure